Today’s standard treatments for patients are based on previous clinical trials and it is important to think of clinical trials as a possible treatment option instead of a last resort. Novel targets and targeted agents in clinical trials showing promise in the treatment of MDS and AML will be discussed. Hear what clinical trials are all about and if they are right for you. The most promising research from the 2021 American Society of Hematology (ASH) will also be presented.
If you enjoyed this event, please help us bring the community more educational opportunities by donating at www.mds-founda....